RET-MAP: An international multi-center study on clinicopathologic features and treatment response in patients with NSCLC and RET fusions

被引：2
|
作者：
Marinello, A. [1 ]
Duruisseaux, M. [2 ]
Zrafi, W. S. [1 ]
Dall'Olio, F. G. [1 ]
Massa, G. [3 ]
Iranzo, P. [4 ]
Tabbo, F. [5 ]
Guisier, F. [6 ]
Lindsay, C. [7 ]
Fallet, V. [8 ]
Audigier-Valette, C. [9 ]
Mezquita, L. [10 ]
Calles, A. [11 ]
Mountzios, G. [12 ,13 ]
Tagliamento, M. [1 ]
Raimbourg, J. [14 ]
Terrisse, S. [15 ]
Planchard, D. [16 ]
Besse, B. [17 ]
Aldea, M. [18 ]
机构：
[1] Inst Gustave Roussy, Canc & Radiat Res Team, Villejuif, France
[2] Louis Pradel Hosp, Hosp Civils Lyon, Inst Canc, Resp Dept, Lyon, France
[3] Fdn IRCCS, Ist Nazl Tumori, Med Oncol Dept, Milan, Italy
[4] Vall Hebron Univ Hosp, Med Oncol Dept, Barcelona, Spain
[5] Univ Torino, Dipartimento Oncol, Orbassano, Italy
[6] CHU Rouen, Hop Charles Nicolle, Rouen, France
[7] Christie NHS Fdn Trust, Med Oncol Dept, Manchester, Lancs, England
[8] Hop Tenon AP HP, Canc Est, Serv Pneumol, Paris, France
[9] Hosp St Musse, Toulon, France
[10] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
[11] Hosp Univ Gregorio Maranon, Madrid, Spain
[12] Henry Dunant Hosp Ctr, Dept Med Oncol 2, Athens, Greece
[13] Henry Dunant Hosp Ctr, Clin Trials Unit, Athens, Greece
[14] ICO Inst Canc Ouest Rene Gauducheau, St Herblain, France
[15] Hop St Louis APHP, Med Oncol, Paris, France
[16] Inst Gustave Roussy, Villejuif, France
[17] Inst Gustave Roussy, Canc Med Dept, Villejuif, France
[18] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
34P
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [21] Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity-a multi-center retrospective study
    Jin, Bei
    Cheng, Cheng
    Tan, Meizhen
    Huang, Jun
    Chen, Lizhi
    Lin, Zhilang
    Zeng, Shuhan
    Yu, Zihua
    Li, Yingjie
    Jiang, Xiaoyun
    LUPUS, 2023, 32 (06) : 791 - 798
  • [22] Clinicopathologic features and treatment efficacy of patients with BRAF V600E-mutated metastatic colorectal cancer: a multi-center real-world propensity score matching study
    Wei, Gui-Xia
    Zhou, Yu-Wen
    Dong, Chao
    Zhang, Tao
    Cao, Peng
    Xie, Lin
    Qiu, Meng
    BMC CANCER, 2024, 24 (01)
  • [23] MIXED RESPONSE TO TOFACITINIB IN INDIAN PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS: A MULTI-CENTER STUDY
    Goel, R.
    Vasanth, P.
    Padiyaru, S.
    Aithala, R.
    Patil, A.
    Jain, A.
    Pinto, B.
    Jois, R.
    Mathew, J.
    Danda, D.
    Joseph, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1560 - 1560
  • [24] EFFECTIVENESS OF DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS. INTERNATIONAL COOPERATIVE MULTI-CENTER STUDY
    Jang, J. H.
    Iastrebner, M.
    Taborda, G.
    Arbelbide, J.
    Sackmann, F.
    Klein, G.
    Bernard, H.
    Jozami, C.
    Kim, K.
    Kim, D.
    Jung, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 553 - 554
  • [25] Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study
    Iastrebner, Marcelo
    Jang, Jun Ho
    Fernandez, Isolda
    Kim, Kihyun
    Garay, Guy
    Kim, Dong Hwan
    Saba, Silvia
    Jung, Chul Won
    Santini, Fernando
    Haydee i Bernard
    Salvatierra, Lino
    Korin, Jorge
    Taborda, Gustavo
    Antonio Giuliani, Ricardo
    Flores, Gabriela
    Flores, Alejandro
    BLOOD, 2009, 114 (22) : 1465 - 1466
  • [26] Religion as a Factor When Treating Homosexual Patients: Results of a Large International Multi-Center Study
    Garcia, Ismael
    Mendez, Yamely
    Surani, Salim
    Marik, Paul
    Varon, Joseph
    CHEST, 2017, 152 (04) : 835A - 835A
  • [27] Efficacy and Safety of Combining Endostar with Camrelizumab plus Chemotherapy in Advanced NSCLC Patients: A Multi-Center Retrospective Study
    Wu, L.
    Pu, X. X.
    Chen, L. B.
    Wang, Z. Q.
    Liu, Y. L.
    Li, K.
    Kong, Y.
    Xu, F.
    Li, J.
    Xu, L.
    Xu, Y.
    Tang, C. Y.
    Xiao, L. M.
    Liu, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S388 - S388
  • [28] Prevalence, clinical characteristics, and treatment outcomes of patients with BRAF-mutated advanced NSCLC in China: A real-world multi-center study
    Jia, B.
    Zhao, J.
    Jin, B.
    Zhang, F.
    Wang, S.
    Zhang, L.
    Wang, Z.
    An, T.
    Wang, Y.
    Zhuo, M.
    Li, J.
    Yang, X.
    Li, S.
    Chen, H.
    Chi, Y.
    Wang, J.
    Zhai, X.
    Tai, Y.
    Liu, Y.
    Guan, G.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S61 - S61
  • [29] Response to: "Racial disparities in mortality among patients with prurigo nodularis: A multi-center cohort study''
    Trepanowski, Nicole
    Huang, Linglin
    Hartman, Rebecca I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : E113 - E113
  • [30] Attainment of Complete Renal Response in Patients with Active Lupus Nephritis: A Multi-Center Cohort Study
    Ramnarain, Arushi
    Xu, Xiaomeng
    Kent, Joanna
    Jagtiani, Sagar
    Louthrenoo, Worawit
    Hamijoyo, Laniyati
    Luo, Shue-Fen
    Chen, Yi-Hsing
    Cho, Jiacai
    Chan, Chiu Wai Shirley
    Navarra, Sandra
    Yao, Haihong
    Pok, Lydia
    Basnayake, B. M. D. B.
    Zhang, Zhuoli
    Chan, Madelynn
    Bae, Sang-Cheol
    Katsumata, Yasuhiro
    Kikuchi, Jun
    O'Neill, Sean
    Goldblatt, Fiona
    Poh, Yih Jia
    Sapsford, Mark
    Tugnet, Nicola
    Ng, Kristine Pek Ling
    Tee, Cherica
    Tanaka, Yoshiya
    Nikpour, Mandana
    Hoi, Alberta
    Morand, Eric
    Kandane-Rathnayake, Rangi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4883 - 4886
12345